- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Small Bowel Neuroendocrine Tumors
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 9, Pages 1395
Publisher
MDPI AG
Online
2019-09-18
DOI
10.3390/cancers11091395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Health-related quality of life for octreotide long-acting vs. placebo in patients with metastatic midgut neuroendocrine tumors in the phase 3 PROMID trial
- (2019) Anja Rinke et al. NEUROENDOCRINOLOGY
- Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors
- (2019) Anna Yordanova et al. CLINICAL NUCLEAR MEDICINE
- Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
- (2018) Jonathan Strosberg et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018
- (2018) Manisha H. Shah et al. Journal of the National Comprehensive Cancer Network
- Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies
- (2018) Christoph J Auernhammer et al. Lancet Diabetes & Endocrinology
- Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival
- (2018) Kosmas Daskalakis et al. JAMA Oncology
- BILIARY STONE DISEASE IN PATIENTS RECEIVING SOMATOSTATIN ANALOGS FOR NEUROENDOCRINE NEOPLASMS. A RETROSPECTIVE OBSERVATIONAL STUDY
- (2018) N. Brighi et al. DIGESTIVE AND LIVER DISEASE
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
- (2018) Guido Rindi et al. MODERN PATHOLOGY
- Management of Small Bowel Neuroendocrine Tumors
- (2018) Aaron T. Scott et al. Journal of Oncology Practice
- Management of Advanced Small Bowel Cancer
- (2018) Alberto Puccini et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
- (2017) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
- (2017) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuroendocrine liver metastasis: The chance to be cured after liver surgery
- (2017) Fabio Bagante et al. JOURNAL OF SURGICAL ONCOLOGY
- Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors
- (2017) Mauro Cives et al. JNCI-Journal of the National Cancer Institute
- Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Marianne E Pavel et al. LANCET ONCOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Surgical Management of Small Bowel Neuroendocrine Tumors
- (2017) James R. Howe et al. PANCREAS
- The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
- (2017) Jonathan R. Strosberg et al. PANCREAS
- Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors
- (2017) Mauro Cives et al. JNCI-Journal of the National Cancer Institute
- Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors.
- (2017) Robert Lance Fine et al. JOURNAL OF CLINICAL ONCOLOGY
- Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
- (2016) Mio Kitano et al. ANNALS OF SURGICAL ONCOLOGY
- Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus
- (2016) Simron Singh et al. CANCER TREATMENT REVIEWS
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- (2016) M. Pavel et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
- (2016) B. Niederle et al. NEUROENDOCRINOLOGY
- Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
- (2015) E. Grande et al. ANNALS OF ONCOLOGY
- Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study
- (2015) Sven-Petter Haugvik et al. ANNALS OF SURGICAL ONCOLOGY
- Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms
- (2015) M Heetfeld et al. ENDOCRINE-RELATED CANCER
- Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
- (2015) Alexandria T Phan et al. LANCET ONCOLOGY
- Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference
- (2015) Andrew Kennedy et al. HPB
- Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
- (2015) Edward Wolin et al. Drug Design Development and Therapy
- Gastroenteropancreatic high-grade neuroendocrine carcinoma
- (2014) Halfdan Sorbye et al. CANCER
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver Transplantation for Neuroendocrine Tumors in Europe—Results and Trends in Patient Selection
- (2013) Yves Patrice Le Treut et al. ANNALS OF SURGERY
- Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours
- (2013) O. Norlén et al. BRITISH JOURNAL OF SURGERY
- Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
- (2013) Robert L. Fine et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Are G3 ENETS neuroendocrine neoplasms heterogeneous?
- (2013) Fritz-Line Vélayoudom-Céphise et al. ENDOCRINE-RELATED CANCER
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
- (2012) H. Sorbye et al. ANNALS OF ONCOLOGY
- Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors
- (2012) Sébastien Gaujoux et al. ANNALS OF SURGICAL ONCOLOGY
- Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases
- (2012) G. Capurso et al. BRITISH JOURNAL OF SURGERY
- Surgery Versus Intra-arterial Therapy for Neuroendocrine Liver Metastasis: A Multicenter International Analysis
- (2011) Skye C. Mayo et al. ANNALS OF SURGICAL ONCOLOGY
- Liver Transplantation for the Treatment of Liver Metastases From Neuroendocrine Tumors
- (2011) Roberto Gedaly ARCHIVES OF SURGERY
- Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours
- (2011) L Medley et al. BRITISH JOURNAL OF CANCER
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Surgical Management of Hepatic Neuroendocrine Tumor Metastasis: Results from an International Multi-Institutional Analysis
- (2010) Skye C. Mayo et al. ANNALS OF SURGICAL ONCOLOGY
- The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas
- (2010) Jonathan R. Strosberg et al. PANCREAS
- Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: Long-term follow-up
- (2010) Hizir Yakup Akyildiz et al. SURGERY
- Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach
- (2010) Akshat Saxena et al. SURGERY
- Prophylactic Cholecystectomy in Midgut Carcinoid Patients
- (2010) Olov Norlén et al. WORLD JOURNAL OF SURGERY
- Long-term survival after surgical management of neuroendocrine hepatic metastases
- (2010) Evan S. Glazer et al. HPB
- Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study
- (2009) A Ahmed et al. ENDOCRINE-RELATED CANCER
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
- (2008) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search